The role of matrix metalloproteinase-9 in dementia

被引：31

作者：

Helbecque, N ^{[1
]}

Hermant, X ^{[1
]}

Cottel, D ^{[1
]}

Amouyel, P ^{[1
]}

机构：

[1] Inst Pasteur, INSERM, U508, F-59019 Lille, France

来源：

NEUROSCIENCE LETTERS | 2003年 / 350卷 / 03期

关键词：

Alzheimer's disease; matrix metalloproteinases; polymorphism; case-control study;

D O I：

10.1016/S0304-3940(03)00905-4

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Neurofibrillary tangles and senile plaques, constituted of extracellular amyloid deposits (Abeta), are the two defining pathological hallmarks of Alzheimer's disease (AD). Inhibiting the synthesis or aggregation of Abeta or increasing its clearance may reduce the detrimental effects of this peptide and consequently improve cognitive functions in patients. Previous studies indicated that metalloprotemases are involved in Abeta degradation and the presence of matrix metalloprotemases (MMP) in AD plaques has been described. In this study, we examined the distribution of a functional polymorphism in the gene for MMP-9, -1562 C --> T, in an independent population of 229 demented and 253 control individuals. We observed a weak protective effect of the high activity allele (T) in apolipoprotein E is an element of4 allele non-bearers (odds ratio = 0.5 (95% confidence interval, 0.3-0.9), P = 0.04). (C) 2003 Elsevier Ireland Ltd. All rights reserved.

引用

页码：181 / 183

页数：3

共 17 条

[1] The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment [J].